Constellation Brands (STZ) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Aug, 2026Executive summary
Achieved 2% net sales growth (3% organic) in FY25 to $10.2B, with substantial comparable operating margin improvement and double-digit comparable EPS growth, despite softer consumer demand and challenging macroeconomic conditions.
Beer Business remained the #1 dollar share gainer in U.S. beverage alcohol, with strong performance from Modelo Especial and Pacifico, and significant share gains among Hispanic consumers.
Completed major portfolio reshaping, including SVEDKA and 2025 Wine Divestitures, to focus on higher-end brands and drive $200M+ in annualized cost savings by FY28.
Returned nearly $1.9B to shareholders in FY25, including over $1.1B in share repurchases and increased quarterly dividend to $1.02 per share.
Maintained disciplined capital allocation, with $1.1B in share repurchases and $732M in dividends in FY25.
Financial highlights
FY25 net sales rose 2% to $10.2B; comparable operating income grew 7% to $3.5B; comparable EPS increased 11% to $13.78; operating cash flow $3.2B; free cash flow $1.94B.
Beer segment net sales up 5% to $8.54B; operating income up 10% to $3.39B; operating margin increased 180 bps to 39.7%.
Wine & Spirits net sales declined 7% to $1.67B; operating income down 18% to $325M, reflecting divestitures.
FY25 reported net loss attributable to CBI of $81M due to non-cash impairments and divestiture impacts.
Achieved comparable net leverage ratio target in FY25, maintained under 3.0x.
Outlook and guidance
FY26 organic enterprise net sales expected to be down 2% to up 1%, reflecting divestitures and new tariffs; comparable EPS guidance: $12.60–$12.90; operating cash flow $2.7B–$2.8B; free cash flow $1.5B–$1.6B.
Beer net sales growth guidance: 0–3% for FY26, 2–4% for FY27–FY28; operating income growth: 0–2% for FY26; operating margins expected at 39–40% for FY26–FY28.
Wine and Spirits organic net sales expected to decline 17–20% in FY26, with operating income to decline 97–100% and margin near zero; improvement expected post-divestiture, with 22–24% operating margins by FY27–FY28.
Cumulative operating cash flow of ~$9B and free cash flow of $6–7B expected from FY26–FY28.
Guidance incorporates the impact of U.S. and Canadian tariffs, including delayed effectiveness for some U.S. tariffs affecting wine and spirits.
Latest events from Constellation Brands
- All director nominees, auditor ratification, and compensation proposals were approved.STZ
AGM 2026 - EPS up 31% and organic sales up 3%, with strong cash flow and FY27 outlook reaffirmed.STZ
Q1 2027 - Shareholders to vote on directors, auditor, pay, and stock plan after leadership changes and strong cash flow.STZ
Proxy filing - Board recommends all proposals, including director elections and compensation, for July 2026 meeting.STZ
Proxy filing - Net sales fell but net income surged, with beer share gains and stable guidance despite headwinds.STZ
Q4 2026 - Q3 FY26 net sales fell 10%, but Beer gained share and cash flow guidance was reaffirmed.STZ
Q3 2026 - EPS rebounded despite lower sales, with Beer leading share gains and Wine & Spirits hit by divestitures.STZ
Q2 2026 - Net sales fell 6% year-over-year; Beer outperformed, Wine & Spirits refocused on premium brands.STZ
Q1 2026 - Beer growth offsets Wine and Spirits decline as FY25 guidance is revised downward.STZ
Q3 2025